N--4-sͪ Ӣ N-Benzoyl-4-perhydroazepinone CAS̖(ho) 15923-40-7
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0113071 | 100mg |
1
|
ԃr(ji) |
Q-0113071 | 250mg |
1
|
ԃr(ji) |
Q-0113071 | 500mg |
1
|
ԃr(ji) |
Q-0113071 | 1g |
1
|
ԃr(ji) |
Q-0113071 | 5g |
1
|
ԃr(ji) |

N--4-sͪQ
N--4-sͪ
Ӣ 1-benzoylazepan-4-one
Ąe N-䵪s-4-ͪ
N--4-sͪW(xu)|(zh)
ܶ 1.15g/cm3
c(din) 389ºC at 760mmHg
ʽ C13H15NO2
217.26400
Wc(din) 178.8ºC
|(zh) 217.11000
PSA 37.38000
P(gun)a(chn)Ʒ
(2R,3R)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoic acid
N-Benzyl-N-methyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine
(R)-1-(2-(Diphenylphosphino)phenyl)ethanamine
2-(Diphenylphosphino)ethanaminium tetrafluoroborate
4'-Fluoro-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-carbonitrile
3-(3-Nitrophenylsulfonamido)propanoic acid
4-(Naphthalen-1-yl)benzoic acid
4'-(Methylthio)-[1,1'-biphenyl]-2-carbonitrile
;
a(chn)أ
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
5-ȼ-2-(4-ȱ)-4-f Ӣ 5-(chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-oxazole ܶ 1.30.1 g/cm3 c(din) 365.252.0 C at 760 mmHg ʽ C11H9Cl2NO
-
N--N'-()-1,6- Ӣ Iodoacetyl-LC-biotin CAS̖(ho) 93285-75-7